FDA-Drug2013-03-06Class II
EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA
Pacira Pharmaceuticals, Inc.
Hazard
Subpotent; bupivacaine
Sold states
Nationwide distribution: AZ, DC, FL, GA, MA, NJ, NY, OH, and TX.
Affected count
324 vials
Manufactured in
10450 Science Center Dr, N/A, San Diego, CA, United States
Products
EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-168-2013Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief